Public
ºÚÁÏÕýÄÜÁ¿ Association content that is available to the public and all website users.
AHA's feedback on a Drug Enforcement Administration proposed rule for the telemedicine prescribing of controlled substances when there has not been a prior in-person medical evaluation.
AHA provides feedback on the Drug Enforcement Administration’s (DEA’s) proposed rule for expansion of induction of buprenorphine via telemedicine encounter.
AHA comments on the FDA's draft guidance proposing that blood donor eligibility be determined based on individual risk assessment, regardless of gender or sexual orientation.
Some experts have suggested that RSV (respiratory syncytial virus) was more severe last year because of an immunity gap from several years of social distancing and COVID-19 precautions.
March 29, 2023
AHA, AHIP Amicus Brief in False Claims Act Case.
AHA Statement before the House Committee on Energy and Commerce Subcommittee on Health regarding Lowering Unaffordable Costs: Examining Transparency and Competition in Health Care.
The AHA writes to express support for the Rural America Health Corps Act (S.940).
AHA Board Chair John Haupert is joined by Robert C. Garrett, CEO of Hackensack Meridian Health, based in New Jersey. In this conversation, Haupert and Garrett discuss the important role of hospitals and health systems in leading medical research and innovation to transform health care and make…